Lung Cancer Diagnostics Market Industry Challenges, Key Vendors, Drivers, Trends and Forecast 2024 : Grand View Research Inc.
San Francisco, 11 April 2019: The Report Lung Cancer Diagnostics Market Analysis By Type (Small Cell Lung Cancer, Non-small Cell Lung Cancer), By Test (Imaging Test, Biopsy, Sputum Cytology, Molecular Testing), And Segment Forecasts To 2024 The global Lung Cancer Diagnostics Market is expected to reach USD 3,644.6 million by 2024, according to a new report by Grand View Research Inc. The development of lung cancer-specific biomarkers is one of the primary factors for the growth of the lung cancer diagnostics market over the forecast period. These diagnostic tools facilitate the personalized treatment approach of lung malignancies. Various biomarkers are present in the research pipeline. For instance, in November 2015, Epigenomics AG announced the launch of a new blood-based test using DNA methylation biomarkers, the development of which is underway. The initial results of this test revealed a promising outcome in the early diagnosis of lung cancer. Furthermore, various